Engene TherapeuticsENGN

13F holders, Q2 2026 (June 30)
56holders +54
21new positions
1sold out
4famous investors
$1.73avg. 13F price*

At the end of Q2 2026, 56 institutions reported holding Engene Therapeutics Inc. (ENGN) in their 13F filings, up 54 from Q1 2026. 21 opened new positions and 1 sold out. The largest holders were BML Capital Management, LLC ($11.5M), Siren, L.L.C. ($10.8M) and Perceptive Advisors LLC ($8.3M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Engene Therapeutics Inc.
CUSIP
29286X101
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2026: 2Q1 2026Q2 2026: 56Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions21$23.2M
Exits1$2.3M

All 13F filers, Q1 2026 → Q2 2026: 18,847,370 shares bought and 3,707,131 shares sold, net +15,140,239 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 56 holders

BML Capital Management, LLC 6.59% New 6,669,908 $11.5M
Siren, L.L.C. 0.22% Add +19.1% 6,256,662 $10.8M
Perceptive Advisors LLC 0.13% Reduce -17.3% 4,822,169 $8.3M
Ameriprise Financial Inc. 0.00% New 2,675,876 $4.6M
Nextech Invest Ltd. 0.19% No change 2,324,943 $4.0M
ADAR1 Capital Management, LLC 0.17% Add +1474.6% 2,104,986 $3.6M
Vestal Point Capital, LP 0.07% Reduce -23.0% 1,667,430 $2.9M
Acorn Capital Advisors, LLC 0.60% New 1,271,257 $2.2M
Peapod Lane Capital LLC 1.29% New 1,102,149 $1.9M
Balyasny Asset Management L.P. 0.00% Reduce -12.3% 1,007,344 $1.7M
Millennium Management 0.00% Add +0.7% 966,627 $1.7M
Renaissance Technologies 0.00% Add +431.5% 829,700 $1.4M
Citadel Advisors 0.00% Add +366.2% 717,686 $1.2M
Affinity Asset Advisors, LLC 0.05% Reduce -1.7% 600,000 $1.0M
UBS Group AG 0.00% Add +3810.9% 509,087 $881K
Eversept Partners, LP 0.04% Reduce -8.0% 469,584 $812K
Kynam Capital Management, LP 0.04% Reduce -66.3% 457,855 $792K
Seven Fleet Capital Management LP 0.12% New 411,065 $711K
Jane Street Group, LLC 0.00% Add +145.2% 382,459 $662K
Rangeley Capital, LLC 0.52% New 305,102 $528K
Barclays PLC 0.00% Add +82506.7% 282,515 $489K
Kennedy Capital Management LLC 0.01% Reduce -36.9% 268,735 $465K
Woodline Partners LP 0.00% No change 250,000 $433K
Quadrature Capital Ltd 0.00% New 239,035 $414K
Squarepoint Ops LLC 0.00% Add +340.5% 215,381 $373K
Elmind Capital, LP 0.09% No change 210,000 $363K
Qube Research & Technologies Ltd 0.00% New 200,187 $346K
Privium Fund Management B.V. 0.05% Reduce -51.7% 170,000 $294K
Two Sigma Investments, LP 0.00% Add +3.5% 164,570 $285K
XTX Topco Ltd 0.00% Add +62.0% 151,424 $262K
Marquette Asset Management, LLC 0.03% New 150,546 $260K
Persistent Asset Partners Ltd 0.06% New 114,493 $198K
DAFNA Capital Management LLC 0.02% Reduce -60.2% 74,650 $129K
Jain Global LLC 0.00% New 43,231 $75K
Scientech Research LLC 0.06% New 40,710 $70K
Verdad Advisers, LP 0.07% New 39,300 $68K
Dimensional Fund Advisors LP 0.00% Add +3.9% 38,291 $66K
Gsa Capital Partners LLP 0.00% New 37,346 $65K
Morgan Stanley 0.00% Reduce -61.8% 33,086 $57K
Engineers Gate Manager LP 0.00% New 27,286 $47K
BNP Paribas Financial Markets 0.00% Reduce -61.1% 25,419 $44K
Susquehanna International Group, LLP 0.00% New 24,470 $42K
Sectoral Asset Management Inc. 0.03% New 21,700 $38K
Raymond James Financial Inc. 0.00% Add +1.7% 21,356 $37K
Sei Investments Co. 0.00% Reduce -69.2% 18,504 $32K
HRT Financial LP 0.00% Reduce -47.4% 16,831 $29K
Point72 Asset Management 0.00% Reduce -91.9% 13,992 $24K
Virtu Financial LLC 0.00% New 13,986 $24K
Royal Bank of Canada 0.00% Add +7.4% 11,325 $20K
PFS Partners, LLC 0.01% No change 11,000 $19K
Wells Fargo & Company 0.00% Reduce -45.1% 6,840 $12K
Wolverine Asset Management LLC 0.00% New 2,964 $5K
Simplex Trading, LLC 0.00% New 399 $690
Farther Finance Advisors, LLC 0.00% New 100 $173
Aquatic Capital Management LLC 0.00% Reduce -97.9% 29 $50
SBI Securities Co., Ltd. 0.00% No change 28 $48

"% of holder's portfolio" is ENGN's weight in each manager's 13F, not the share of Engene Therapeutics Inc. the manager owns.